Search Results - "Kızılocak, Hande"

Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors by Kızılocak, Hande, Okcu, Fatih

“…Over the last 50 years, the survival rates in children with acute lymphoblastic leukemia (ALL) have increased remarkably. The optimal use of antileukemic…”
Get full text

Wernicke's Encephalopathy in a Child with Acute Lymphoblastic Leukemia by Kızılocak, Hande, Özdemir, Gül Nihal, Dikme, Gürcan, Haşıloğlu, Zehra Işık, Celkan, Tiraje

Get full text

Febrile Neutropenia in Children with Cancer: Approach to Diagnosis and Treatment by Kebudi, Rejin, Kizilocak, Hande

“…Febrile neutropenia is one of the major acute side effects of intensive treatment in pediatric cancer, necessitating prompt initiation of empirical…”
Get more information

Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays by Kizilocak, Hande, Yukhtman, Clara Lana, Marquez-Casas, Elizabeth, Lee, Jeanie, Donkin, Jennifer, Young, Guy

“…Background: Patients with severe hemophilia A and inhibitors are at risk of bleeding during invasive procedures. The standard of care for preventing…”
Get full text

Late Effects of Therapy in Childhood Acute Lymphoblastic Leukemia Survivors by Kızılocak, Hande, Okçu, Fatih

Get full text

Osteosarcoma After Hematopoietic Stem Cell Transplantation in Children and Adolescents: Case Report and Review of the Literature by Kebudi, Rejin, Ozger, Harzem, Kızılocak, Hande, Bay, Sema Buyukkapu, Bilgiç, Bilge

“…Osteosarcoma as a secondary malignancy after hematopoietic stem cell transplantation (HSCT) is very rare. We present a case and review of 18 other cases…”
Get full text

Successful outcome of mucormycosis in a child with acute lymphoblastic leukemia by kebudi, rejin

“…Invasive fungal infections may cause morbidity and mortality in pediatric patients with hematologic and oncologic malignancies treated with intensive…”
Get full text

Treatment of plasminogen deficiency patients with fresh frozen plasma by Kızılocak, Hande, Ozdemir, Nihal, Dikme, Gürcan, Koç, Begüm, Atabek, Ayşe Ayzıt, Çokuğraş, Haluk, İskeleli, Güzin, Dönmez‐Demir, Buket, Christiansen, Nina Merete, Ziegler, Maike, Ozdağ, Hilal, Schuster, Volker, Celkan, Tiraje

“…Congenital plasminogen (Plg) deficiency leads to the development of ligneous membranes on mucosal surfaces. Here, we report our experience with local and…”
Get full text

Diagnosis and treatment of hemophilia by Kizilocak, Hande, Young, Guy

“…Hemophilia A and B are inherited bleeding disorders characterized by deficiency or dysfunction of coagulation protein factors VIII and IX, respectively…”
Get full text

Emerging drugs for hemophilia A: insights into phase II and III clinical trials by Kizilocak, Hande, Young, Guy

“…Hemophilia is a lifelong, genetic-bleeding disorder, which inadequately treated results in permanent joint damage. It is characterized by spontaneous and…”
Get more information

Discrepancy between the Results of One-Stage and Chromogenic Factor VIII Assays: Switch in Diagnosis from Mild to Moderate Hemophilia a in Three Cases by Kizilocak, Hande, Keegan, Jackie, Young, Guy

Get full text

Neutralizing antidrug antibody to emicizumab in a patient with severe hemophilia A with inhibitors: New case with detailed laboratory evaluation by Harkins Druzgal, Colleen, Kizilocak, Hande, Brown, Joshua, Sennett, Margaret, Young, Guy

“…Hemophilia A is an inherited bleeding disorder characterized by deficiency of the coagulation protein factor VIII. Development of clotting factor concentrates…”
Get full text

Neutralizing antidrug antibody to emicizumab in patients with severe hemophilia A: Case report of a first noninhibitor patient and review of the literature by Kizilocak, Hande, Guerrera, Michael F., Young, Guy

“…Hemophilia A (HA) is a genetic bleeding disorder characterized by the deficiency of the coagulation protein factor (F) VIII (FVIII). The development of…”
Get full text

Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab by Kizilocak, Hande, Marquez‐Casas, Elizabeth, Malvar, Jemily, Young, Guy

“…Introduction Emicizumab is a humanized bispecific monoclonal antibody licensed for patients with severe haemophilia A. Breakthrough bleeding still occurs in…”
Get full text

PP-291. Comparison of histopathological placental findings in preterm and term births by Babayigit, Aslan, Salihoglu, Ozgul, Koc, Begum Sirin, Seven, Nurten, Kızılocak, Hande, Hatipoglu, Sami

Get full text

Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays by Kizilocak, Hande, Marquez‐Casas, Elizabeth, Malvar, Jemily, Carmona, Roxana, Young, Guy

“…Introduction Emicizumab is a recombinant, humanized bispecific monoclonal antibody that mimics the function of factor VIII (FVIII) which results in a…”
Get full text

Factor VIII Level Comparison in Patients with Severe Hemophilia a on Emicizumab with Inhibitors with One Stage, Bovine and Human Chromogenic Assays and the Factor VIII Equivalency of Emicizumab Using In Vivo Global Hemostasis Assays by Kizilocak, Hande, Marquez-Casas, Elizabeth, Brown, Joshua, Malvar, Jemily, Young, Guy

“…Introduction Emicizumab is a recombinant, humanized bispecific monoclonal antibody that mimics the function of factor VIII (FVIII) which results in a…”
Get full text

Factor VIII Level Comparison in Patients with Severe Hemophilia a on Emicizumab with Inhibitors with One Stage, Bovine and Human Chromogenic Assays and the Factor VIII Equivalency of Emicizumab Using In Vivo G lobal Hemostasis Assays by Kizilocak, Hande, Marquez-Casas, Elizabeth, Brown, Joshua, Malvar, Jemily, Young, Guy

“…Abstract Introduction Emicizumab is a recombinant, humanized bispecific monoclonal antibody that mimics the function of factor VIII (FVIII) which results in a…”
Get full text

Comparison of bypassing agents in patients on emicizumab using global hemostasis assays by Kizilocak, Hande, Marquez‐Casas, Elizabeth, Phei Wee, Choo, Malvar, Jemily, Carmona, Roxana, Young, Guy

“…Introduction Emicizumab is a humanized bispecific monoclonal antibody licensed for patients with severe haemophilia A with and without inhibitors. Management…”
Get full text

Five-year-old girl with tongue bleeding by Kızılocak, Hande, Özdemir, Nihal, Varol, Fatih, Koç, Begüm Şirin, Dikme, Gürcan, Çam, Halit, Celkan, Tiraje

Get full text